Research and development work at Novartis shows that managed access programs have become more critical than ever. In this case study, learn how Novartis streamlined its internal processes to cut the time to process approvals and ship drugs in less than 24 hours.
For physicians and their patients who are in urgent need of treatment and have otherwise exhausted their options, access to pharmaceuticals through managed access programs — to compounds that might have clinical utility — have become literally a matter of life and death. Access this important report for valuable insights from Novartis on:
Offered Free by: Bonterra
See All Resources from: Bonterra
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.